DRL may contest Pfizer patent suit
Jan. 5: Dr Reddy’s Laboratories (DRL) is likely to contest a patent infringement case filed against it by global pharma giant Pfizer over its cholesterol lowering drug atorvastatin.
Dr Reddy’s had fi
Jan. 5: Dr Reddy’s Laboratories (DRL) is likely to contest a patent infringement case filed against it by global pharma giant Pfizer over its cholesterol lowering drug atorvastatin.
Dr Reddy’s had fi
No Articles Found
No Articles Found
No Articles Found